MarketPeel
Chief Executive Officer
Tue, Jun 30, 2026
Jun 30
sold $1.50m of MLYS
58,000 shares @ $25.94
Decreased holdings by -8.40%
3rd largest trade (out of 42)
Planned (10b5-1)Large TradePositive 90D History
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 30, 2025.Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
70% win rate · +34.2% median edge vs SPY (10 trades, 90-day · small sample)
Price 18% below 200-day moving average
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
MLYSMineralys Therapeutics, Inc.
HealthcareBiotechnology
1D0.00%
1W-1.54%
1M-3.97%
3M-14.47%
6M
1Y

Recent insider activity at MLYS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback